FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006864562> ?p ?o ?g. }

• W2006864562 endingPage "300" @default.
• W2006864562 startingPage "293" @default.
• W2006864562 abstract "The estrogen receptor (ER) pathway and the epidermal growth factor receptor (EGFR) pathway play pivotal roles in breast cancer progression. Targeted therapies able to intercept ER or signaling downstream to EGFR and its kin, HER2, are routinely used to treat distinct groups of breast cancer patients. However, patient responses are limited by resistance to endocrine therapy, which may be due to compensatory HER2/EGFR signaling. This raises the possibility that simultaneous interception of HER2 and ER may enhance therapeutic efficacy. To address the question, we treated breast cancer cells with both fulvestrant (ICI 182780), an ER antagonist with no agonist effects, and lapatinib, an orally available tyrosine kinase inhibitor specific to EGFR and HER2. Our results indicate that the combination of drugs is especially effective when applied to HER2-overexpressing, ER-positive cancer cells. Interestingly, fulvestrant activated the mitogen-activated protein kinase (MAPK) pathway of these cells, but complete inhibition of MAPK signaling was observed on cotreatment with lapatinib. Taken together, our observations reinforce the possibility that the effectiveness of combining anti-ER and anti-HER2/EGFR drugs may be especially effective on a relatively small subtype of HER2-overexpressing, ER-positive tumors of the breast." @default.
• W2006864562 created "2016-06-24" @default.
• W2006864562 creator A5002134047 @default.
• W2006864562 creator A5003423974 @default.
• W2006864562 creator A5004932556 @default.
• W2006864562 creator A5016902113 @default.
• W2006864562 creator A5038055187 @default.
• W2006864562 creator A5044227350 @default.
• W2006864562 creator A5081716847 @default.
• W2006864562 date "2011-10-01" @default.
• W2006864562 modified "2023-10-16" @default.
• W2006864562 title "Simultaneous Inhibition of Estrogen Receptor and the HER2 Pathway in Breast Cancer: Effects of HER2 Abundance" @default.
• W2006864562 cites W1549373117 @default.
• W2006864562 cites W1964321121 @default.
• W2006864562 cites W1981938678 @default.
• W2006864562 cites W1982729445 @default.
• W2006864562 cites W2012877952 @default.
• W2006864562 cites W2016386722 @default.
• W2006864562 cites W2016569614 @default.
• W2006864562 cites W2017021495 @default.
• W2006864562 cites W2033894757 @default.
• W2006864562 cites W2041998309 @default.
• W2006864562 cites W2066516593 @default.
• W2006864562 cites W2071275412 @default.
• W2006864562 cites W2086224272 @default.
• W2006864562 cites W2095156669 @default.
• W2006864562 cites W2097698108 @default.
• W2006864562 cites W2098637021 @default.
• W2006864562 cites W2105455633 @default.
• W2006864562 cites W2108725521 @default.
• W2006864562 cites W2117357260 @default.
• W2006864562 cites W2125785648 @default.
• W2006864562 cites W2131475305 @default.
• W2006864562 cites W2138317169 @default.
• W2006864562 cites W2140055441 @default.
• W2006864562 cites W2142072523 @default.
• W2006864562 cites W2142334766 @default.
• W2006864562 cites W2142882987 @default.
• W2006864562 cites W2145355816 @default.
• W2006864562 cites W2145657357 @default.
• W2006864562 cites W2147673480 @default.
• W2006864562 cites W2148320836 @default.
• W2006864562 cites W2159415114 @default.
• W2006864562 cites W2159459001 @default.
• W2006864562 cites W2164484108 @default.
• W2006864562 cites W2169625143 @default.
• W2006864562 cites W2321112275 @default.
• W2006864562 cites W2332928500 @default.
• W2006864562 cites W4293395719 @default.
• W2006864562 doi "https://doi.org/10.1593/tlo.11127" @default.
• W2006864562 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3162304" @default.
• W2006864562 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21966546" @default.
• W2006864562 hasPublicationYear "2011" @default.
• W2006864562 type Work @default.
• W2006864562 sameAs 2006864562 @default.
• W2006864562 citedByCount "23" @default.
• W2006864562 countsByYear W20068645622012 @default.
• W2006864562 countsByYear W20068645622013 @default.
• W2006864562 countsByYear W20068645622014 @default.
• W2006864562 countsByYear W20068645622015 @default.
• W2006864562 countsByYear W20068645622016 @default.
• W2006864562 countsByYear W20068645622017 @default.
• W2006864562 countsByYear W20068645622018 @default.
• W2006864562 countsByYear W20068645622019 @default.
• W2006864562 countsByYear W20068645622020 @default.
• W2006864562 crossrefType "journal-article" @default.
• W2006864562 hasAuthorship W2006864562A5002134047 @default.
• W2006864562 hasAuthorship W2006864562A5003423974 @default.
• W2006864562 hasAuthorship W2006864562A5004932556 @default.
• W2006864562 hasAuthorship W2006864562A5016902113 @default.
• W2006864562 hasAuthorship W2006864562A5038055187 @default.
• W2006864562 hasAuthorship W2006864562A5044227350 @default.
• W2006864562 hasAuthorship W2006864562A5081716847 @default.
• W2006864562 hasBestOaLocation W20068645621 @default.
• W2006864562 hasConcept C121608353 @default.
• W2006864562 hasConcept C126322002 @default.
• W2006864562 hasConcept C170493617 @default.
• W2006864562 hasConcept C2777329042 @default.
• W2006864562 hasConcept C2779438470 @default.
• W2006864562 hasConcept C2779786085 @default.
• W2006864562 hasConcept C2780482068 @default.
• W2006864562 hasConcept C42362537 @default.
• W2006864562 hasConcept C502942594 @default.
• W2006864562 hasConcept C530470458 @default.
• W2006864562 hasConcept C57074206 @default.
• W2006864562 hasConcept C62478195 @default.
• W2006864562 hasConcept C71924100 @default.
• W2006864562 hasConcept C84606932 @default.
• W2006864562 hasConcept C86803240 @default.
• W2006864562 hasConcept C95444343 @default.
• W2006864562 hasConcept C98274493 @default.
• W2006864562 hasConceptScore W2006864562C121608353 @default.
• W2006864562 hasConceptScore W2006864562C126322002 @default.
• W2006864562 hasConceptScore W2006864562C170493617 @default.
• W2006864562 hasConceptScore W2006864562C2777329042 @default.
• W2006864562 hasConceptScore W2006864562C2779438470 @default.
• W2006864562 hasConceptScore W2006864562C2779786085 @default.
• W2006864562 hasConceptScore W2006864562C2780482068 @default.

• next